US Patent Issued to Immedica Pharma on July 7 for "Method and composition for treating arginase 1 deficiency" (Texas, Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,093, issued on July 7, was assigned to Immedica Pharma AB (Stockholm).

"Method and composition for treating arginase 1 deficiency" was invented by Scott W. Rowlinson (Austin, Texas), Anthony G. Quinn (Gloucester, Mass.), Ann Lowe (Austin, Texas) and David Lowe (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method and composition to treat a subject with arginase 1 (ARG1) deficiency (ARG1-D) and to rapidly reduce the levels of at least one of arginine and/or a guanidino compound in the subject."

The patent was filed on June 29, 2023, under Application No. 18/344,083.

*For further information, including images, charts and tables, plea...